Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy
2022 · Advances in Radiation Oncology · 23 citations
https://doi.org/10.1016/j.adro.2022.100959
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
298
Citations
10
h-index
10
i10-index
Anirudh Yalamanchali is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Inflammatory Biomarkers in Disease Prognosis & Head and Neck Cancer Studies. The author has an h-index of 10, co-authored 26 publications.
ORCID: 0000-0002-7216-2282https://doi.org/10.1016/j.adro.2022.100959
https://doi.org/10.1016/j.adro.2020.08.002
Click to start Chat